By merging our expertise in fine organic synthesis, material development, and biological evaluation, Nissan Chemical has developed two pharmaceuticals—Livalo® and Landel®. We are actively advancing research and development in pharmaceuticals, focusing on oligonucleotide therapeutics, materials for regenerative medicine, and other healthcare areas to further expand our capabilities.
Key Healthcare Focus Areas
Oligonucleotide Drug Discovery: Innovative oligonucleotide drug discovery using our proprietary platform through in-house research and collaborations.
Regenerative Medicine: Floating and dispersible cell culture scaffold (FCeM®) and cell/protein adhesion control coating materials (prevelex®) for cell and gene therapy.
Diagnostics: Specialty materials and reagents for next-generation assays.
Interests for Open Innovation
We are seeking technologies and partners to accelerate our drug discovery efforts, including:
- New drug discovery collaboration partner using our oligonucleotide platforms
- Novel oligonucleotide drug delivery platforms (e.g., LNP, polymers, conjugates)
- Advanced cell culture and processing technologies (e.g. room temperature cell storage)
- Next-Generation diagnostic assay platforms (e.g., biosensors, microfluidics)
- Biomarker discovery and validation tools